All our discussions are focused on Infant Formula - but we are all aware this is only the tip of the iceberg. We are talking about a slumbering giant in milk consumption. China is slowly moving in milk consumption as long as enough fresh/pasteurized A2-milk is available. The Dairy World would have a big problem with sudden increase…!
Have also a look to India - their population is also categorized as 70 - 80 % lactose-intolerant but they are the largest milk producer in the world (160 mio. t). They consume all the milk in India! Why?
50 % Buffaloes milk (a2a2)
3 % Goat milk (a2a2)
47 % Cow milk, from which 70 % belong to Bos indicus type cattle (a2a2)
The dairy world with the support of the WHO has to move into the A2A2 era, if we want to feed the fast growing global population with superior protein and fatty acids (PUFA´s).
Too many members of HC have no clue about the Dairy Market and change their minds from day to day - I just can tell you - in 20 years time all cows have to be a2a2
So don´t be afraid as LT investor - our time will come (sooner than later)
- Forums
- ASX - By Stock
- A2M
- A2 Analyst Valuations
A2 Analyst Valuations, page-32
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.959B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $8.098M | 1.173M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 11669 | $6.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.85 | 10265 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 8740 | 6.840 |
18 | 47723 | 6.830 |
16 | 54440 | 6.820 |
11 | 79798 | 6.810 |
5 | 6254 | 6.800 |
Price($) | Vol. | No. |
---|---|---|
6.850 | 11217 | 22 |
6.860 | 14348 | 11 |
6.870 | 47400 | 15 |
6.880 | 47509 | 12 |
6.890 | 16733 | 13 |
Last trade - 15.58pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online